-
WCG KMR Group Invites Biopharmaceutical Companies to Enroll in Clinical Trial Cost Study
Sep 17, 2019, 10:13 AM by Michael CroftPRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now openFull story -
Celsee Issued New Patent for Single-Cell Capture System
Sep 17, 2019, 09:18 AM by Michael CroftANN ARBOR, MI, UNITED STATES - Sep 17, 2019 - Celsee, Inc., today announced the issuance of U.S. Patent No. 10,416,070, entitled Cell capture system and method of use, which covers the automation of single-cell partitioningFull story -
Certara Introduces its Hasharc Decentralized Application for Healthcare at the Launch of Hedera Hashgraph Open Access
Sep 17, 2019, 08:30 AM by Michael CroftPRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)Full story -
Creative Biolabs Provides Anti-CXCR4 Antibody for Research Use
Sep 17, 2019, 03:09 AM by Michael CroftSHIRLEY, NY - Sep 16, 2019 - September 16, 2019, Creative Biolabs, as a leading supplier in antibody production field, recently announced anti cxcr4 antibody and the related anti-cxcr4 dasatinib to assist researchers research projectsFull story -
Everest Medicines Expands Senior Leadership Team
Sep 16, 2019, 12:50 PM by Michael CroftNEW YORK, NY, UNITED STATES - Sep 16, 2019 - Shanghai and New York - September 16, 2019 - Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced Everest Medicine's founding member, DrFull story -
Could Using CRISPR To Edit Embryos Save People Who Are Already Alive?
Sep 16, 2019, 12:41 PM by Michael CroftSTAT | The technology is not advanced enough yet, but the idea of editing DNA to produce a savior sibling may be theoretically possible.Full story -
Space Is The New Frontier For Life Sciences Research
Sep 16, 2019, 07:35 AM by Michael CroftFull storyBio-IT World | Advances in microfluidics, the shift from animal-based to cell-based models of drug research, and the ability to grow larger and more perfect protein crystals in microgravity have all helped propel space-based research into a thriving commercial enterprise.
-
Glowing Cholesterol A Game-Changer For Study Of Heart Disease
Sep 13, 2019, 10:05 AM by Michael CroftFull storyBio-IT World | A new technique that lights up a protein shuttling LDL cholesterol around the circulatory system has made it financially feasible to do high-throughput screening for cardiovascular drugs as well as measure the size of LDL particles—an important but poorly-understood disease risk factor.
-
Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets
Sep 12, 2019, 09:36 AM by Michael CroftThe New York Times | Drugs can stop cancer cells if they attack the right proteins. But many of these targets were chosen with dated, imprecise technology, a new study suggests.Full story -
National Maternal and Infant Health Crisis Spurs 30 Health Systems to Take Action
Sep 12, 2019, 09:20 AM by Michael CroftCHICAGO, IL, UNITED STATES - Sep 12, 2019 - CHICAGO - September 12, 2019 - In response to the national maternal health epidemic, 30 large health systems are banding together to find and put forward solutions to this crisis in their communitiesFull story -
Signant Health Brings Its eConsent Solution to China for Large Neuroscience Study in Collaboration with Shanghai Mental Health Center
Sep 12, 2019, 09:14 AM by Michael CroftPHILADELPHIA, PA, US - Sep 12, 2019 - Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC)Full story -
Shimmer Announces Launch of Healthcare Industry Open Source Initiative for Wearable Sensor Algorithms
Sep 12, 2019, 08:58 AM by Michael CroftCAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithmsFull story -
Certara Launches Version 8.2 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software for Drug Development
Sep 12, 2019, 08:42 AM by Michael CroftPRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8Full story -
TraceLink Demonstrates Continued Global Momentum with Strong Q2 2019 Results
Sep 12, 2019, 06:50 AM by Michael Croft, UNITED KINGDOM - Sep 12, 2019 - 75 percent increase in new U.S. bookings, large revenue growth in APAC and India, and largest FutureLink conference to date among highlights North Reading, MA (August XX, 2019)-TraceLink IncFull story -
Supporting medical researchers working with large complex datasets of proteins, genes and metabolites
Sep 12, 2019, 06:26 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Sep 12, 2019 - OverviewYale University in Connecticut, USA, owns one of the world's great medical historical librariesFull story -
Sharp Expands its Clinical Operations to European Facility
Sep 12, 2019, 05:41 AM by Michael CroftHEERENVEEN, NETHERLANDS - Sep 12, 2019 - Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen, NetherlandsFull story -
Elsevier Joins Forces with Pharmaceutical Industry Leaders to Build New Drug–Drug Interaction Risk Calculator
Sep 11, 2019, 11:25 AM by Michael CroftNEW YORK, NY, UNITED STATES - Sep 11, 2019 - Elsevier, the global information analytics business specializing in science and health, is working together with a set of evaluation partners that include industry leaders such as Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier, and others to develop a new and improved drug–drug interaction risk calculator (DDIRC)Full story -
Life Image Announces New Value-Added Solution that Further Enhances the Google Cloud Healthcare API to De-Identify Patient Information in Medical Imaging Data
Sep 10, 2019, 13:02 PM by Michael CroftNEWTON, MA - Sep 10, 2019 - Life Image, one of the world's largest global networks for sharing clinical and imaging data that is powered by leading interoperability standards, today announced the launch of a new enhancement and validation service that optimizes the de-identification functionality of the Google Cloud Healthcare API, which helps to power healthcare insights for security and compliance-focused environmentsFull story -
Spring Bank Annouces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance
Sep 10, 2019, 10:09 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Sep 4, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has entered into a $20 million convertible debt financing agreement with Pontifax Medison Finance, a healthcare-dedicated venture debt fundFull story -
FDA Extends CRADA with CluePoints to Further Explore a Data-Driven Approach to Quality Oversight in Clinical Trials
Sep 10, 2019, 09:13 AM by Michael CroftKING OF PRUSSIA, US - Sep 10, 2019 - FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical researchFull story